Practice question

Answer the question and get instant feedback.

MediumCardiologyHeart failure with reduced ejection fractionukmlamrcgp aktmrcp part 1prescribing safety assessment

A 58-year-old woman with HFrEF (LVEF 32%) remains NYHA class II despite an ACE inhibitor and a beta-blocker at target doses. Which single addition is most appropriate now?

Educational content. Not a substitute for clinical judgement or local policy.